Oxford Asset Management Sells 25,993 Shares of Varian Medical Systems, Inc. (VAR)

Oxford Asset Management reduced its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 29.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 63,390 shares of the company’s stock after selling 25,993 shares during the period. Oxford Asset Management’s holdings in Varian Medical Systems were worth $5,691,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. Ngam Advisors L.P. boosted its position in shares of Varian Medical Systems by 15.0% in the second quarter. Ngam Advisors L.P. now owns 342,437 shares of the company’s stock valued at $28,159,000 after buying an additional 44,783 shares during the period. Mitsubishi UFJ Trust & Banking Corp boosted its position in shares of Varian Medical Systems by 10.2% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 541,430 shares of the company’s stock valued at $53,889,000 after buying an additional 50,163 shares during the period. Decatur Capital Management Inc. bought a new position in shares of Varian Medical Systems during the third quarter valued at $3,072,000. Confluence Investment Management LLC boosted its position in shares of Varian Medical Systems by 9.2% in the third quarter. Confluence Investment Management LLC now owns 38,371 shares of the company’s stock valued at $3,819,000 after buying an additional 3,222 shares during the period. Finally, TD Asset Management Inc. boosted its position in shares of Varian Medical Systems by 5.5% in the third quarter. TD Asset Management Inc. now owns 93,300 shares of the company’s stock valued at $9,286,000 after buying an additional 4,872 shares during the period. Institutional investors own 99.79% of the company’s stock.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems, Inc. (NYSE:VAR) traded up 0.34% during midday trading on Tuesday, hitting $80.44. The stock had a trading volume of 221,105 shares. The company has a market capitalization of $7.52 billion, a PE ratio of 22.90 and a beta of 0.69. The stock’s 50-day moving average is $86.28 and its 200-day moving average is $92.05. Varian Medical Systems, Inc. has a 1-year low of $66.08 and a 1-year high of $93.97.

This piece of content was originally reported by sleekmoney and is owned by of sleekmoney. If you are reading this piece of content on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The legal version of this piece of content can be read at http://sleekmoney.com/oxford-asset-management-sells-25993-shares-of-varian-medical-systems-inc-var/1660496.html.

VAR has been the subject of several recent analyst reports. Zacks Investment Research cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. Jefferies Group LLC restated a “buy” rating and set a $102.00 target price on shares of Varian Medical Systems in a research report on Friday, December 23rd. Aegis initiated coverage on Varian Medical Systems in a research report on Monday, February 6th. They set a “hold” rating and a $85.00 target price for the company. RBC Capital Markets set a $93.00 target price on Varian Medical Systems and gave the stock a “hold” rating in a research report on Monday, January 23rd. Finally, Evercore ISI cut Varian Medical Systems from a “hold” rating to a “sell” rating and set a $81.50 target price for the company. in a research report on Thursday, January 26th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. Varian Medical Systems presently has a consensus rating of “Hold” and a consensus price target of $92.23.

In related news, SVP John W. Kuo sold 1,267 shares of the company’s stock in a transaction dated Thursday, December 8th. The shares were sold at an average price of $90.33, for a total transaction of $114,448.11. Following the completion of the transaction, the senior vice president now owns 24,027 shares in the company, valued at approximately $2,170,358.91. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Dow R. Wilson sold 13,334 shares of the company’s stock in a transaction dated Thursday, January 5th. The stock was sold at an average price of $88.74, for a total transaction of $1,183,259.16. Following the transaction, the insider now owns 77,625 shares of the company’s stock, valued at approximately $6,888,442.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,601 shares of company stock valued at $2,198,007. Insiders own 0.91% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

5 Day Chart for NYSE:VAR

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/oxford-asset-management-sells-25993-shares-of-varian-medical-systems-inc-var/1660496.html

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *